We are looking for 2 to 17 years old to join a CD clinical trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or ulcerative colitis (UC) (including associated symptoms such as abdominal cramps, kidney stones, constant need to poop, frequent fevers and/or anemia), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the CD and UC studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
